Ocular Therapeutix shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Ocular Therapeutix
Tip: Access up to 7 years of quarterly data
All positions including Ocular Therapeutix held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ocular Therapeutix by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $50M | 5.9M | 8.47 |
| 2025-12-31 | $2.1M | 172k | 12.14 |
| 2025-09-30 | $1.5M | 132k | 11.69 |
| 2025-06-30 | $1.2M | 126k | 9.28 |
| 2025-03-31 | $922k | 126k | 7.33 |
| 2024-12-31 | $5.5M | 639k | 8.54 |
| 2024-09-30 | $8.5M | 977k | 8.70 |
| 2024-06-30 | $7.6M | 1.1M | 6.85 |
| 2024-03-31 | $6.0M | 663k | 9.10 |
| 2023-12-31 | $238k | 53k | 4.46 |
| 2023-09-30 | $128k | 41k | 3.16 |
| 2023-06-30 | $200k | 39k | 5.18 |
| 2023-03-31 | $202k | 38k | 5.27 |
| 2022-12-31 | $118k | 42k | 2.82 |
| 2022-03-31 | $98k | 20k | 4.96 |
| 2021-12-31 | $92k | 13k | 6.94 |
| 2021-09-30 | $346k | 35k | 10.01 |
| 2021-06-30 | $491k | 35k | 14.17 |
| 2021-03-31 | $540k | 33k | 16.41 |
| 2020-12-31 | $537k | 26k | 20.71 |